Advicenne S.A.

Advicenne S.A.

ALDVI · Euronext Paris

Advicenne S.A. (ALDVI) is a Biotechnology company in the Healthcare sector, listed on Euronext Paris. This page provides the complete earnings calendar, dividend schedule, and financial data for Advicenne S.A. in 2026. The next earnings report is expected on September 17, 2026.

Earnings calendar

Next earnings date

17 Sep 2026

In 29 days

EPS estimate

—

Revenue estimate

3.1M

Past earnings

19 Sep 2025
EPS actual
-0.47
Revenue actual
3.8M (+24.0%)
estimate 3.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Revenue exceeded consensus estimates, with US$3.84 million in sales surpassing forecasts by 24.0%, while EPS was a loss of US$0.4712. No prior report is available for comparison.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.

Sector
Healthcare
Industry
Biotechnology
Country
France
Exchange
Euronext Paris
CEO
Didier Laurens
Employees
11
IPO date
06 Dec 2017
ISIN
FR0013296746
Website
advicenne.com

Frequently asked questions

When does Advicenne S.A. (ALDVI) next report earnings?

Advicenne S.A. (ALDVI) is scheduled to report earnings on September 17, 2026.

What was Advicenne S.A.'s most recent earnings date?

Advicenne S.A. (ALDVI) last reported earnings on September 19, 2025.

Where is Advicenne S.A. stock listed?

Advicenne S.A. (ALDVI) is listed on Euronext Paris.